Advertisement
Screener

JPMORGAN CHASE & CO (JPM) Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold

JPMORGAN CHASE & CO Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold

JPMORGAN CHASE & CO (JPM) reported Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold of $0 for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-23.

Discontinued › Expense Statement › Operating Expenses

us-gaap:OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsReductionsSecuritiesSold · last filed 2016-02-23

  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for the quarter ending 2014-09-30 was $0.00.
  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for the quarter ending 2014-06-30 was $0.00.
  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for the quarter ending 2013-12-31 was $519.00M, a 142.52% increase year-over-year.
  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for fiscal 2015 was $0.00.
  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for fiscal 2013 was $522.00M, a 143.93% increase from fiscal 2012.
  • JPMORGAN CHASE & CO other than temporary impairment, credit losses recognized in earnings, reductions, securities sold for fiscal 2012 was $214.00M.
Period endOther than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold 3 monthOther than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold 3 month as first filedOther than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold 6 monthOther than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold 6 month as first filedOther than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold 9 monthOther than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Securities Sold 12 month
2015-12-31$0.00
10-K · filed 2016-02-23
2014-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23
$0.00
derived: sum of 2 quarters · filed 2016-02-23
$0.00
derived: sum of 3 quarters · filed 2016-02-23
$0.00
10-K · filed 2016-02-23
2014-09-30$0.00
10-Q · filed 2014-11-03
$0.00
derived: sum of 2 quarters · filed 2014-11-03
$0.00
10-Q · filed 2014-11-03
2014-06-30$0.00
10-Q · filed 2014-08-04
$0.00
10-Q · filed 2014-08-04
2013-12-31$519.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23
$519.00M
derived: sum of 2 quarters · filed 2016-02-23
$519.00M
derived: sum of 3 quarters · filed 2016-02-23
$522.00M
10-K · filed 2016-02-23
2013-09-30$0.00
10-Q · filed 2014-11-03
$0.00
derived: sum of 2 quarters · filed 2014-11-03
$3.00M
10-Q · filed 2014-11-03
$217.00M
derived: sum of 4 quarters · filed 2015-02-24
2013-06-30$0.00
10-Q · filed 2014-08-04
$3.00M
10-Q · filed 2014-08-04
-$3.00M
10-Q · filed 2013-08-07
$217.00M
derived: sum of 3 quarters · filed 2015-02-24
$217.00M
derived: sum of 4 quarters · filed 2015-02-24
2013-03-31$3.00M
10-Q · filed 2014-05-02
-$3.00M
10-Q · filed 2013-05-08
$217.00M
derived: sum of 2 quarters · filed 2015-02-24
$217.00M
derived: sum of 3 quarters · filed 2015-02-24
$217.00M
derived: sum of 4 quarters · filed 2015-02-24
2012-12-31$214.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24
$214.00M
derived: sum of 2 quarters · filed 2015-02-24
$214.00M
derived: sum of 3 quarters · filed 2015-02-24
$214.00M
10-K · filed 2015-02-24
2012-09-30$0.00
10-Q · filed 2013-11-01
$0.00
derived: sum of 2 quarters · filed 2013-11-01
$0.00
10-Q · filed 2013-11-01
$0.00
derived: sum of 4 quarters · filed 2014-02-20
2012-06-30$0.00
10-Q · filed 2013-08-07
$0.00
10-Q · filed 2013-08-07
$0.00
derived: sum of 3 quarters · filed 2014-02-20
$0.00
derived: sum of 4 quarters · filed 2014-02-20
2012-03-31$0.00
10-Q · filed 2013-05-08
$0.00
derived: sum of 2 quarters · filed 2014-02-20
$0.00
derived: sum of 3 quarters · filed 2014-02-20
$0.00
derived: sum of 4 quarters · filed 2014-02-20
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20
$0.00
derived: sum of 2 quarters · filed 2014-02-20
$0.00
derived: sum of 3 quarters · filed 2014-02-20
$0.00
10-K · filed 2014-02-20
2011-09-30$0.00
10-Q · filed 2011-11-04
$0.00
derived: sum of 2 quarters · filed 2011-11-04
$0.00
10-Q · filed 2011-11-04
2011-06-30$0.00
8-K · filed 2011-11-04
$0.00
8-K · filed 2011-11-04
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$8.00M
derived: sum of 2 quarters · filed 2013-02-28
$28.00M
derived: sum of 3 quarters · filed 2013-02-28
$31.00M
10-K · filed 2013-02-28
2010-09-30$8.00M
10-Q · filed 2011-11-04
$28.00M
derived: sum of 2 quarters · filed 2011-11-04
$31.00M
10-Q · filed 2011-11-04
2010-06-30$20.00M
8-K · filed 2011-11-04
$23.00M
8-K · filed 2011-11-04
2009-12-31$0.00
10-K · filed 2012-02-29